269 related articles for article (PubMed ID: 22766481)
21. Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease.
Tiraboschi P; Hansen LA; Alford M; Merdes A; Masliah E; Thal LJ; Corey-Bloom J
Arch Gen Psychiatry; 2002 Oct; 59(10):946-51. PubMed ID: 12365882
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.
DeKosky ST; Ikonomovic MD; Styren SD; Beckett L; Wisniewski S; Bennett DA; Cochran EJ; Kordower JH; Mufson EJ
Ann Neurol; 2002 Feb; 51(2):145-55. PubMed ID: 11835370
[TBL] [Abstract][Full Text] [Related]
23. Brain-derived neurotrophic factor modified human umbilical cord mesenchymal stem cells-derived cholinergic-like neurons improve spatial learning and memory ability in Alzheimer's disease rats.
Hu W; Feng Z; Xu J; Jiang Z; Feng M
Brain Res; 2019 May; 1710():61-73. PubMed ID: 30586546
[TBL] [Abstract][Full Text] [Related]
24. Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer's neuropathology.
Ikonomovic MD; Mufson EJ; Wuu J; Cochran EJ; Bennett DA; DeKosky ST
J Alzheimers Dis; 2003 Feb; 5(1):39-48. PubMed ID: 12590165
[TBL] [Abstract][Full Text] [Related]
25. Human Cortical Neural Stem Cells Expressing Insulin-Like Growth Factor-I: A Novel Cellular Therapy for Alzheimer's Disease.
McGinley LM; Sims E; Lunn JS; Kashlan ON; Chen KS; Bruno ES; Pacut CM; Hazel T; Johe K; Sakowski SA; Feldman EL
Stem Cells Transl Med; 2016 Mar; 5(3):379-91. PubMed ID: 26744412
[TBL] [Abstract][Full Text] [Related]
26. Impaired hippocampal acetylcholine release parallels spatial memory deficits in Tg2576 mice subjected to basal forebrain cholinergic degeneration.
Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
Brain Res; 2014 Jan; 1543():253-62. PubMed ID: 24231553
[TBL] [Abstract][Full Text] [Related]
27. Selective antitumor effect of neural stem cells expressing cytosine deaminase and interferon-beta against ductal breast cancer cells in cellular and xenograft models.
Yi BR; Hwang KA; Aboody KS; Jeung EB; Kim SU; Choi KC
Stem Cell Res; 2014 Jan; 12(1):36-48. PubMed ID: 24141111
[TBL] [Abstract][Full Text] [Related]
28. Nerve growth factor pharmacology: application to the treatment of cholinergic neurodegeneration in Alzheimer's disease.
Lapchak PA
Exp Neurol; 1993 Nov; 124(1):16-20. PubMed ID: 8282073
[TBL] [Abstract][Full Text] [Related]
29. A human neural stem cell line provides neuroprotection and improves neurological performance by early intervention of neuroinflammatory system.
Watanabe T; Nagai A; Sheikh AM; Mitaki S; Wakabayashi K; Kim SU; Kobayashi S; Yamaguchi S
Brain Res; 2016 Jan; 1631():194-203. PubMed ID: 26620543
[TBL] [Abstract][Full Text] [Related]
30. Correlation of nicotinic binding with neurochemical markers in Alzheimer's disease.
Sabbagh MN; Reid RT; Corey-Bloom J; Rao TS; Hansen LA; Alford M; Masliah E; Adem A; Lloyd GK; Thal LJ
J Neural Transm (Vienna); 1998; 105(6-7):709-17. PubMed ID: 9826113
[TBL] [Abstract][Full Text] [Related]
31. Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease.
Yasuhara T; Matsukawa N; Hara K; Yu G; Xu L; Maki M; Kim SU; Borlongan CV
J Neurosci; 2006 Nov; 26(48):12497-511. PubMed ID: 17135412
[TBL] [Abstract][Full Text] [Related]
32. Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer's disease.
Ubhi K; Rockenstein E; Vazquez-Roque R; Mante M; Inglis C; Patrick C; Adame A; Fahnestock M; Doppler E; Novak P; Moessler H; Masliah E
J Neurosci Res; 2013 Feb; 91(2):167-77. PubMed ID: 23152192
[TBL] [Abstract][Full Text] [Related]
33. Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis.
Scott SA; Mufson EJ; Weingartner JA; Skau KA; Crutcher KA
J Neurosci; 1995 Sep; 15(9):6213-21. PubMed ID: 7666203
[TBL] [Abstract][Full Text] [Related]
34. Designer Self-Assemble Peptides Maximize the Therapeutic Benefits of Neural Stem Cell Transplantation for Alzheimer's Disease via Enhancing Neuron Differentiation and Paracrine Action.
Cui GH; Shao SJ; Yang JJ; Liu JR; Guo HD
Mol Neurobiol; 2016 Mar; 53(2):1108-1123. PubMed ID: 25586060
[TBL] [Abstract][Full Text] [Related]
35. NGF-cholinergic dependency in brain aging, MCI and Alzheimer's disease.
Cuello AC; Bruno MA; Bell KF
Curr Alzheimer Res; 2007 Sep; 4(4):351-8. PubMed ID: 17908036
[TBL] [Abstract][Full Text] [Related]
36. Stem cell therapy for Alzheimer's disease.
Abdel-Salam OM
CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):459-85. PubMed ID: 21495961
[TBL] [Abstract][Full Text] [Related]
37. Repeated nicotine exposure in rats: effects on memory function, cholinergic markers and nerve growth factor.
Hernandez CM; Terry AV
Neuroscience; 2005; 130(4):997-1012. PubMed ID: 15652996
[TBL] [Abstract][Full Text] [Related]
38. Deep Brain Magnetic Stimulation Promotes Neurogenesis and Restores Cholinergic Activity in a Transgenic Mouse Model of Alzheimer's Disease.
Zhen J; Qian Y; Fu J; Su R; An H; Wang W; Zheng Y; Wang X
Front Neural Circuits; 2017; 11():48. PubMed ID: 28713248
[TBL] [Abstract][Full Text] [Related]
39. The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease.
Counts SE; Mufson EJ
J Neuropathol Exp Neurol; 2005 Apr; 64(4):263-72. PubMed ID: 15835262
[TBL] [Abstract][Full Text] [Related]
40. Alzheimer's disease and neural transplantation as prospective cell therapy.
Oliveira AA; Hodges HM
Curr Alzheimer Res; 2005 Jan; 2(1):79-95. PubMed ID: 15977991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
